Xuancheng Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xuancheng Fu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Bowen Xu
Department of Chemistry, Syracuse University, Syracuse, New York, 13244, USA
4 shared publications- Xiaoran Hu
Department of Chemistry Syracuse University Syracuse New York 13244 USA
4 shared publications - Fengting Lv
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids
3 shared publications - Libing Liu
Department of Nutrition and Health, China Agricultural University, Beijing 100193, China
3 shared publications Luke G. Westbrook
Department of Chemistry Syracuse University Syracuse New York 13244 USA
3 shared publications- Shu Wang
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing, PR China
3 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (13) , 6643-6652
A photosensitizer-drug conjugate for synergistic photodynamic therapy and photo-triggered camptothecin release
Red-light-responsive nanoparticles enable singlet oxygen-mediated thioketal cleavage and controlled camptothecin release for synergistic chemo–photodynamic therapy.
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (13) , 6643-6652
Open AccessA photosensitizer-drug conjugate for synergistic photodynamic therapy and photo-triggered camptothecin release
Red-light-responsive nanoparticles enable singlet oxygen-mediated thioketal cleavage and controlled camptothecin release for synergistic chemo–photodynamic therapy.
- Open Access
- 18 January 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (9)
A Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation
Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.
- 18 January 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (9)
Open AccessA Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation
Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.
- Open Access
- 18 January 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (9) , e15594
A Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation
Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.
- 18 January 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (9) , e15594
Open AccessA Noncovalent Click‐to‐Release Strategy to Control Bond Cleavage and Prodrug Activation
Click‐to‐release chemistry enables bioorthogonal bond cleavage and controlled release via a click‐type ligation reaction serving as both the trigger and means of localization. Extending this concept beyond covalent ligation reactions, we introduce a noncovalent click‐to‐release strategy based on cucurbit[7]uril‐adamantane (CB‐Ad) association. The CB host molecule forms a pre‐assembled host‐guest complex with a self‐immolative guest (SIG) SIG1, where the masked SIG remains inert. Introduction of a high‐affinity guest Ad initiates the CB‐Ad noncovalent click reaction, displacing SIG1 and triggering its self‐immolation and cargo release. As a proof‐of‐concept, we used a prototype prodrug SIG2 to demonstrate our strategy's potential for controlled therapeutic release, effectively regulating the photodynamic cell killing in vitro. This noncovalent click‐to‐release approach broadens the structural and functional scope of bioorthogonal cleavage strategies with promising implications for stimuli‐responsive materials and biomedical applications.
- Open Access
- 12 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (44) , 21000-21009
Ultrasound-triggered prodrug activation via sonochemically induced cleavage of a 3,5-dihydroxybenzyl carbamate scaffold
Deep-penetrating low-intensity therapeutic ultrasound (LITUS) induces the cleavage of a 3,5-dihydroxybenzyl carbamate (DHBC) prodrug scaffold via a sonochemical activation mechanism, enabling spatiotemporally controlled drug release.
- 12 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (44) , 21000-21009
Open AccessUltrasound-triggered prodrug activation via sonochemically induced cleavage of a 3,5-dihydroxybenzyl carbamate scaffold
Deep-penetrating low-intensity therapeutic ultrasound (LITUS) induces the cleavage of a 3,5-dihydroxybenzyl carbamate (DHBC) prodrug scaffold via a sonochemical activation mechanism, enabling spatiotemporally controlled drug release.
- 22 March 2023
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 10 (6) , 2226-2236
A biophotonic device based on a conjugated polymer and a macrophage-laden hydrogel for triggering immunotherapy
A biophotonic device is fabricated for employing a flexible OLED to excite conjugated polymer PPV in a macrophage (M0)-laden 3D printed hydrogel, resulting in the generation of ROS and subsequent M1 macrophage polarization for tumor immunotherapy.
- 22 March 2023
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 10 (6) , 2226-2236
A biophotonic device based on a conjugated polymer and a macrophage-laden hydrogel for triggering immunotherapy
A biophotonic device is fabricated for employing a flexible OLED to excite conjugated polymer PPV in a macrophage (M0)-laden 3D printed hydrogel, resulting in the generation of ROS and subsequent M1 macrophage polarization for tumor immunotherapy.
- 13 September 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (38) , 18128-18132
Simultaneous and visual detection of multiple dopes by an aptamer/AuNPs sensor
Point-of-care testing (POCT) has exhibited broad applications owing to its rapid on-site detection capability under resource-limited conditions. However, most POCT sensors can only detect single substance in each assay, which does not meet the requirements of simultaneous multi-components analysis in most cases. Herein, we report a simple POCT sensor for simultaneously analyzing multiple dopes in minutes. This sensor is composed of gold nanoparticles (AuNPs) assembled with several aptamers. The coating of aptamers on the surface of AuNPs prevents nanoparticles from aggregating in a high-salt environment. In the presence of dopes, the stronger interaction between aptamers and dopes induces the stripping of aptamers from the AuNPs, following the AuNP aggregation in high-salt conditions which further results in a significant color change of the solution. Introducing multi-aptamers in a suitable ratio, we achieved the simultaneous and visual detection of three dopes in one sensor. The linear ranges were determined as 0.1–10 μM for dexamethasone, 0.5–100 μM for salbutamol, and 0.05–10 μM for ractopamine, with detection limits of 53 nM, 130 nM, and 11 nM for the above targets, respectively. The feasibility of this method in practical application was also confirmed via blood and urine samples. Compared with traditional targeting single dopes POCT sensors, this multi-dopes detecting sensor better matches the real demands required during dopes testing. Meanwhile, this label-free approach for simultaneous multi-component detection broadens the application of POCT towards simultaneous multi-target analysis.
- 13 September 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (38) , 18128-18132
Simultaneous and visual detection of multiple dopes by an aptamer/AuNPs sensor
Point-of-care testing (POCT) has exhibited broad applications owing to its rapid on-site detection capability under resource-limited conditions. However, most POCT sensors can only detect single substance in each assay, which does not meet the requirements of simultaneous multi-components analysis in most cases. Herein, we report a simple POCT sensor for simultaneously analyzing multiple dopes in minutes. This sensor is composed of gold nanoparticles (AuNPs) assembled with several aptamers. The coating of aptamers on the surface of AuNPs prevents nanoparticles from aggregating in a high-salt environment. In the presence of dopes, the stronger interaction between aptamers and dopes induces the stripping of aptamers from the AuNPs, following the AuNP aggregation in high-salt conditions which further results in a significant color change of the solution. Introducing multi-aptamers in a suitable ratio, we achieved the simultaneous and visual detection of three dopes in one sensor. The linear ranges were determined as 0.1–10 μM for dexamethasone, 0.5–100 μM for salbutamol, and 0.05–10 μM for ractopamine, with detection limits of 53 nM, 130 nM, and 11 nM for the above targets, respectively. The feasibility of this method in practical application was also confirmed via blood and urine samples. Compared with traditional targeting single dopes POCT sensors, this multi-dopes detecting sensor better matches the real demands required during dopes testing. Meanwhile, this label-free approach for simultaneous multi-component detection broadens the application of POCT towards simultaneous multi-target analysis.
- 22 January 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (14)
Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme
Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.
- 22 January 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (14)
Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme
Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.
- 22 January 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (14) , e202116457
Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme
Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.
- 22 January 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (14) , e202116457
Selective Fluorescence Imaging of Cancer Cells Based on ROS‐Triggered Intracellular Cross‐Linking of Artificial Enzyme
Inside living cells, regulation of catalytic activity of artificial enzymes remains challenging due to issues such as biocompatibility, efficiency, and stability of the catalyst, by which the practical applications of artificial enzymes have been severely hindered. Here, an artificial enzyme, PTT‐SGH, with responsiveness to reactive oxygen species (ROS), was obtained by introducing a catalytic histidine residue to pentaerythritol tetra(3‐mercaptopropionate) (PTT). The artificial enzyme formed large aggregates in cells via the intracellular ROS‐mediated oxidation of thiol groups. The process was significantly facilitated in tumor cells because of the higher ROS concentration in the tumor microenvironment. The catalytic activity of this artificial enzyme was intensively enhanced through deprotonation of cross‐linked PTT‐SGH, which showed typical esterase activities. Selective fluorescence imaging of tumor cells was achieved using the artificial enzyme to trigger the cleavage of the ester bond of the caged fluorophore inside living cells.
- 11 March 2020
- Published by Springer Nature in Chemical Research in Chinese Universities
- Vol. 36 (2) , 237-242
Conjugated Polymer Nanomaterials for Phototherapy of Cancer
- 11 March 2020
- Published by Springer Nature in Chemical Research in Chinese Universities
- Vol. 36 (2) , 237-242
Conjugated Polymer Nanomaterials for Phototherapy of Cancer